AbbVie Unit Fails To Revive Dermal Filler Patent On Appeal
A European appeals panel has rejected an AbbVie subsidiary's quest to restore a dermal filler patent following a challenge from a German rival, saying that the contents of the blueprint are...To view the full article, register now.
Already a subscriber? Click here to view full article